Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacement therapies. Cellino’s vision is transform medicine to enhance healthspan for billions across generations.
| Website | http://www.cellinobio.com |
| Revenue | $12 million |
| Employees | 108 (39 on RocketReach) |
| Founded | 2017 |
| Address | 750 Main Street, Cambridge, Massachusetts 02139, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+21 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Science and Engineering, Other Healthcare Technology Systems |
| Keywords | Biomanufacturing, Regenerative Medicine, Cell Therapy, Tissue Engineering, Cell Manufacturing, Personalized Medicine, Bioprocessing, Cell Culture, Advanced Therapies, Bioreactor Technology, Pluripotent Stem Cells, Biotechnology, Pharmaceutical Manufacturing, Therapeutic Applications, Clinical Manufacturing, Drug Development, Medical Technology |
| Competitors | Amgen, Regeneron, Moderna Therapeutics, Intellia Therapeutics, Inc., CRISPR Therapeutics, CureVac, Synthego Corporation, Zymergen, Inc., TiGenix, Benchmark Genetics +34 more (view full list) |
Looking for a particular Cellino employee's phone or email?
The Cellino annual revenue was $12 million in 2026.
Marinna Madrid is the Co-Founder, Chief Product and Regulatory Officer of Cellino.
39 people are employed at Cellino.
Cellino is based in Cambridge, Massachusetts.